Medical Developments International (MDI)
Nancy Amin, MSL-cert, MSc, MBBS, is a seasoned professional in clinical project management, currently serving as a Senior Clinical Trial Manager at Thermo Fisher Scientific since August 2021 and as a Clinical Project Manager at Medical Developments International since November 2020. With extensive experience in the clinical research field, Nancy has held various roles including Senior Clinical Project Manager at Avance Clinical, Clinical Project Lead at Syneos Health, and Regional Project Manager at Eli Lilly and Company. A strong background is evident from previous positions at Medpace, PRA Health Sciences, ICON Clinical Research, and Hemispherx Biopharma, highlighting expertise in clinical trial management. Educational credentials include a Master of Science in Pharmaceutical Sciences from Temple University and a Bachelor of Medicine, Bachelor of Surgery from Cairo University.
This person is not in any teams
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.